Additional Proxy Soliciting Materials (definitive) (defa14a)
June 25 2018 - 05:12PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a) of the Securities
Exchange
Act of 1934 (Amendment No. )
Filed
by Registrant
|
[X]
|
|
|
Filed
by Party other than Registrant
|
[ ]
|
|
|
Check
the appropriate box:
|
|
[ ]
|
Preliminary
Proxy Statement
|
[ ]
|
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
|
[ ]
|
Definitive
Proxy Statement
|
[X]
|
Definitive
Additional Materials
|
|
|
|
[ ]
|
Soliciting
Materials Pursuant to §240.14a-12
|
|
|
COCRYSTAL
PHARMA, INC.
(Name
of Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
|
|
|
[X]
|
No
fee required.
|
|
|
[ ]
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title
of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate
number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which
the filing fee is calculated and state how it was determined):
|
|
|
|
|
|
$_____
per share as determined under Rule 0-11 under the Exchange Act.
|
|
|
|
|
(4)
|
Proposed
maximum aggregate value of transaction:
|
|
|
|
|
(5)
|
Total
fee paid:
|
|
|
|
[ ]
|
Fee
paid previously with preliminary materials.
|
[ ]
|
Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date
of its filing.
|
|
(1)
|
Amount
previously paid:
|
|
|
|
|
(2)
|
Form,
Schedule or Registration Statement No.:
|
|
|
|
|
(3)
|
Filing
Party:
|
|
|
|
|
(4)
|
Date
Filed:
|
IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
FOR THE STOCKHOLDER MEETING TO BE HELD ON AUGUST 6, 2018
DATE:
AUGUST 6, 2018
|
|
|
|
|
|
TIME:
AT 2:00 PM EASTERN TIME
|
|
|
|
|
|
LOCATION:
4400 BISCAYNE BOULEVARD, MIAMI, FLORIDA 33137
|
|
|
THIS
COMMUNICATION REPRESENTS A NOTICE TO ACCESS A MORE COMPLETE SET OF PROXY MATERIALS (INCLUDING THE
PROXY STATEMENT, FORM 10-K,
AS AMENDED, AND PROXY CARD
) AVAILABLE TO YOU ON THE INTERNET. WE ENCOURAGE YOU TO ACCESS AND REVIEW ALL OF THE IMPORTANT INFORMATION
CONTAINED IN THE PROXY MATERIALS BEFORE VOTING. THE PROXY MATERIALS ARE AVAILABLE AT: http://www.equitystock.com.
|
●
|
IF
YOU DECIDE TO VIEW THE PROXY MATERIALS AND VOTE YOUR SHARES ONLINE,
|
|
|
|
|
|
Step
1: Go to http://www.equitystock.com.
|
|
|
Step
2: Click the “Vote Your Proxy” link.
|
|
|
Step
3: Click on the logo of Cocrystal Pharma, Inc.
|
|
|
Step
4: To view or download the proxy materials, click on the link that describes the material you wish to view or download. For
example, to view or download the Proxy Statement, click on the “Proxy Statement” link.
|
|
|
Step
5: To vote online, click on the designated link and follow the on-screen instructions. YOU MAY VOTE ONLINE UNTIL
7:00 PM
EASTERN TIME ON AUGUST 5, 2018
.
|
|
|
|
|
●
|
IF
YOU WANT TO RECEIVE A PAPER COPY OF THE PROXY MATERIALS INCLUDING THE PROXY CARD, YOU MUST REQUEST ONE. THERE IS NO CHARGE
TO YOU FOR REQUESTING A COPY. TO FACILITATE TIMELY DELIVERY PLEASE MAKE THE REQUEST, AS INSTRUCTED BELOW, BEFORE
JULY 17,
2018
.
|
HOW TO REQUEST PAPER COPIES OF OUR MATERIALS
|
|
|
|
|
|
|
|
|
|
|
|
|
PHONE:
|
FAX:
|
INTERNET:
|
EMAIL:
|
CALL TOLL FREE
|
SEND THIS CARD TO
|
www.equitystock.com
|
proxy@equitystock.com
|
1-855-557-4647
|
1-646-201-9006
|
FOLLOW THE ON-SCREEN INSTRUCTIONS.
|
INCLUDE YOUR CONTROL ID IN YOUR EMAIL.
|
|
|
|
|
How
to attend the meeting and vote in person:
Please come to 4400 BISCAYNE BOULEVARD, MIAMI, FLORIDA 33137 on august 6, 2018 at
2:00 PM eastern time to attenD the meeting and vote in person.
The
board of directors recommends that you vote “for” the following:
|
1.
|
To
elect six members to the Board of Directors.
|
|
|
|
|
|
Nominees
:
|
|
1a.
|
Raymond
Schinazi
|
|
|
|
|
1b.
|
Gary
Wilcox
|
|
|
|
|
1c.
|
David
Block
|
|
|
|
|
1d.
|
Phillip
Frost
|
|
|
|
|
1e.
|
Jane
Hsiao
|
|
|
|
|
1f.
|
Steven
Rubin
|
|
2.
|
To
approve an amendment to Cocrystal’s Certificate of Incorporation to reduce the number of shares of common stock Cocrystal
is authorized to issue from 800,000,000 to 100,000,000.
|
|
|
|
|
3.
|
To
approve, on an advisory basis, Cocrystal’s Named Executive Officer compensation.
|
|
|
|
|
4.
|
To
ratify the appointment of Cocrystal’s independent registered public accounting firm for the fiscal year ending December
31, 2018.
|
Note
:
Such other business as may properly come before the meeting or any adjournment or postponement thereof.
THE
BOARD OF DIRECTORS HAS FIXED THE CLOSE OF BUSINESS ON
JUNE 11, 2018
AS THE RECORD DATE FOR THE DETERMINATION OF MEMBERS
ENTITLED TO RECEIVE NOTICE OF THE ANNUAL MEETING AND TO VOTE OUR ORDINARY SHARES THEY HELD ON THAT DATE AT THE MEETING OR ANY
POSTPONEMENT OR ADJOURNMENT OF THE MEETING.
PLEASE
NOTE–THIS IS NOT A PROXY CARD - YOU CANNOT VOTE BY RETURNING THIS CARD. TO VOTE YOUR SHARES, YOU MUST VOTE ONLINE OR REQUEST
A PAPER COPY OF PROXY MATERIALS TO RECEIVE A PROXY CARD.
IF
YOU WISH TO ATTEND AND VOTE AT THE MEETING, PLEASE BRING THIS NOTICE.
YOUR
VOTE IS IMPORTANT!
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Feb 2024 to Mar 2024
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Mar 2023 to Mar 2024